Episode 81 - Clarke Attwell - CEO Claris Biotherapeutics

Today, we’re joined by Clarke Atwell, CEO of Claris Biotherapeutics — a company pioneering regenerative biologic therapies with a focus on transforming the field of ophthalmology.Under Clarke’s leadership, Claris has achieved a major milestone with its Series A financing, fueling the company’s mission to advance novel therapies designed to repair and restore vision at the cellular level, and are now in the process of going through there series B round. By combining cutting-edge biology with a deep understanding of ocular disease, Claris is working to address some of the most challenging conditions in eye health.Clarke’s career spans scientific innovation and executive leadership across the biopharma industry, and he now leads Claris through an exciting new chapter of growth and clinical translation.